Trial Profile
Effect of Symbicort nasal exhalation for eosinophilic rhinosinusitis with bronchial asthma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 24 Aug 2017
Price :
$35
*
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Asthma; Rhinosinusitis
- Focus Therapeutic Use
- 24 Aug 2017 New trial record